AChE and BChE are both well-known enzymatic targets for treatment of Alzheimer’s disease (AD), and AChE and BChE inhibitors (AChEI and BChEI, respectively) have long been of interest. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.